Welcome to AntoXa Corporation’s newsroom.
For media inquiries, please contact:
Stacey Curry Gunn
Director of Communications
stacey.curry.gunn@antoxacorp.com
519.827.1131
See below for links to the latest AntoXa news.
AntoXa Corporation awarded contract extension with federal government to develop plant-made protein for potential coronavirus therapy
Continue reading ...
AntoXa awarded federal government contract for anti-nerve agent enzyme
Continue reading ...
Ashley J. Meyers appointed President and COO of AntoXa Corporation
Continue reading ...
Ron Hosking appointed to AntoXa Corporation Board of Directors
Continue reading ...
AntoXa Corporation granted Defence R&D Canada license for novel, plant-made anti-ricin antibody
Continue reading ...